(Q34087743)

30 July 2017

title

Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells (English)

1 reference

30 July 2017

1 reference

1 reference

hepatocellular carcinoma

1 reference

1 reference

Xiuying Liu

1

1 reference

30 July 2017

Tianyi Wang

series ordinal

2

1 reference

30 July 2017

Takaji Wakita

series ordinal

3

1 reference

30 July 2017

Wei Yang

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 December 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

398

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

57-67

1 reference

Targeting lipid metabolism in the treatment of hepatitis C virus infection

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

miR-15 and miR-16 induce apoptosis by targeting BCL2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Quantitation of HCV RNA using real-time PCR and fluorimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

MicroRNA expression in cytogenetically normal acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

MicroRNA responses to cellular stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

MicroRNA control of Nodal signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Regulation of the hepatitis C virus genome replication by miR-199a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Cellular microRNA and P bodies modulate host-HIV-1 interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Interferon modulation of cellular microRNAs as an antiviral mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Activation of Ribosomal RNA Transcription by Hepatitis C Virus Involves Upstream Binding Factor Phosphorylation via Induction of Cyclin D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Global epidemiology of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Nucleotide Sequences and Modifications That Determine RIG-I/RNA Binding and Signaling Activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.036

10.1016/J.VIROL.2009.11.036

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference